ResMed | RMD - Net Income

Stock Price
224.96
Daily Change
0.87 0.39%
Monthly
-11.06%
Yearly
5.62%
Q2 Forecast
217.34

ResMed reported $392.59M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Cochlear AUD 161.5M 69.6M Dec/2025
Cooper Companies USD 130.8M 46.2M Dec/2025
CSL USD 401M 96.5M Dec/2025
Dexcom USD 267.3M 16.5M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Fisher Paykel Healthcare NZD 213M 11M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -1.7M 3.7M Dec/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD 68.3M 168.7M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Philips EUR 395M 211M Dec/2025
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 192.9M 1000K Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025